Clinical Trials Directory

Trials / Unknown

UnknownNCT05582824

Lactate Metabolism in the Hypoperfused Critically Ill

Lactate Metabolism in Patientens With Hyperlactatemia-associated Metabolic Acidosis

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Investigating lactate metabolism in critically ill patients whom are hypoperfused by preforming metabolomics via liquid chromatography-mass spectrometry.

Detailed description

Lactate concentration is well known to be directly correlated with risk of death during admission to intensive care. However, lactate by itself is not considered toxic. The study is observational. The breakdown of lactate is being investigated by collecting blood- and urinsamples from patients with hyperlactatemia as a result of hypoperfusion. Levels of lactate, and known as well as unknown metabolites will be identified and quantified by metabolomics. Metabolomics is performed using a combination of liquid chromatography and mass spectrometry. Data will be analysed via statistical analysis to investigate corelations between lactate, a given metabolite and hard outcome such as mortality. And thereby lay the groundwork for potential further research regarding specific lactate-metabolites.

Conditions

Interventions

TypeNameDescription
OTHERBlood and urine testDaily blood and urine samples

Timeline

Start date
2022-09-15
Primary completion
2022-11-01
Completion
2023-01-01
First posted
2022-10-17
Last updated
2022-10-17

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05582824. Inclusion in this directory is not an endorsement.